Liann Abu Salman1, Jordana B Cohen1,2. 1. Renal-Electrolyte and Hypertension Division. 2. Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Abstract
PURPOSE OF REVIEW: Several recent trials and observational studies have identified critical areas that can help to improve the management and measurement of blood pressure in patients with hypertension. RECENT FINDINGS: High-quality trial evidence supports intensive SBP lowering to 110-130 mmHg in older patients, potassium- based salt substitution in patients without chronic kidney disease, and chlorthalidone for the management of hypertension in patients with chronic kidney disease. In addition, population-based studies indicate enormous underdiagnosis of primary aldosteronism as well as greater sustained intensification of antihypertensive therapy in older patients by maximizing medication dosage rather than adding new agents. The prevalence of hypertension is stable worldwide, though is generally improving in high-income countries and worsening in low-income countries. Furthermore, although cuffless blood pressure devices have the potential to improve access to blood pressure measurement, they have not yet demonstrated sufficient accuracy for clinical use. SUMMARY: Growing evidence supports intensive blood pressure lowering, sodium reduction, targeted antihypertensive treatment and appropriate screening for secondary hypertension to optimize blood pressure control and reduce the risk of target organ damage from hypertension. Future studies are needed to identify ways to improve our ability to implement these findings in routine clinical practice.
PURPOSE OF REVIEW: Several recent trials and observational studies have identified critical areas that can help to improve the management and measurement of blood pressure in patients with hypertension. RECENT FINDINGS: High-quality trial evidence supports intensive SBP lowering to 110-130 mmHg in older patients, potassium- based salt substitution in patients without chronic kidney disease, and chlorthalidone for the management of hypertension in patients with chronic kidney disease. In addition, population-based studies indicate enormous underdiagnosis of primary aldosteronism as well as greater sustained intensification of antihypertensive therapy in older patients by maximizing medication dosage rather than adding new agents. The prevalence of hypertension is stable worldwide, though is generally improving in high-income countries and worsening in low-income countries. Furthermore, although cuffless blood pressure devices have the potential to improve access to blood pressure measurement, they have not yet demonstrated sufficient accuracy for clinical use. SUMMARY: Growing evidence supports intensive blood pressure lowering, sodium reduction, targeted antihypertensive treatment and appropriate screening for secondary hypertension to optimize blood pressure control and reduce the risk of target organ damage from hypertension. Future studies are needed to identify ways to improve our ability to implement these findings in routine clinical practice.
Authors: Alexander A Leung; Stella S Daskalopoulou; Kaberi Dasgupta; Kerry McBrien; Sonia Butalia; Kelly B Zarnke; Kara Nerenberg; Kevin C Harris; Meranda Nakhla; Lyne Cloutier; Mark Gelfer; Maxime Lamarre-Cliche; Alain Milot; Peter Bolli; Guy Tremblay; Donna McLean; Karen C Tran; Sheldon W Tobe; Marcel Ruzicka; Kevin D Burns; Michel Vallée; G V Ramesh Prasad; Steven E Gryn; Ross D Feldman; Peter Selby; Andrew Pipe; Ernesto L Schiffrin; Philip A McFarlane; Paul Oh; Robert A Hegele; Milan Khara; Thomas W Wilson; S Brian Penner; Ellen Burgess; Praveena Sivapalan; Robert J Herman; Simon L Bacon; Simon W Rabkin; Richard E Gilbert; Tavis S Campbell; Steven Grover; George Honos; Patrice Lindsay; Michael D Hill; Shelagh B Coutts; Gord Gubitz; Norman R C Campbell; Gordon W Moe; Jonathan G Howlett; Jean-Martin Boulanger; Ally Prebtani; Gregory Kline; Lawrence A Leiter; Charlotte Jones; Anne-Marie Côté; Vincent Woo; Janusz Kaczorowski; Luc Trudeau; Ross T Tsuyuki; Swapnil Hiremath; Denis Drouin; Kim L Lavoie; Pavel Hamet; Jean C Grégoire; Richard Lewanczuk; George K Dresser; Mukul Sharma; Debra Reid; Scott A Lear; Gregory Moullec; Milan Gupta; Laura A Magee; Alexander G Logan; Janis Dionne; Anne Fournier; Geneviève Benoit; Janusz Feber; Luc Poirier; Raj S Padwal; Doreen M Rabi Journal: Can J Cardiol Date: 2017-03-10 Impact factor: 5.223
Authors: Rajiv Agarwal; Arjun D Sinha; Andrew E Cramer; Mary Balmes-Fenwick; Jazmyn H Dickinson; Fangqian Ouyang; Wanzhu Tu Journal: N Engl J Med Date: 2021-11-05 Impact factor: 176.079
Authors: Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright Journal: Hypertension Date: 2017-11-13 Impact factor: 9.897